These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3479720)

  • 1. Physicians' attitudes toward and knowledge about generic drug substitution.
    Friedman D; Jaffe A; Steinhardt S
    N Y State J Med; 1987 Oct; 87(10):539-42. PubMed ID: 3479720
    [No Abstract]   [Full Text] [Related]  

  • 2. Physicians' attitudes toward generic drug substitution by pharmacists.
    Brust M; Hawkins CF; Grayson D
    Tex Med; 1990 Mar; 86(3):45-9. PubMed ID: 2333636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A physician survey on generic drugs and substitution of critical dose medications.
    Banahan BF; Kolassa EM
    Arch Intern Med; 1997 Oct; 157(18):2080-8. PubMed ID: 9382664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General practitioners' views on generic medication and substitution.
    Tilyard MW; Dovey SM; Rosenstreich D
    N Z Med J; 1990 Jul; 103(893):318-20. PubMed ID: 2371006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland.
    Heikkilä R; Mäntyselkä P; Hartikainen-Herranen K; Ahonen R
    Health Policy; 2007 Aug; 82(3):366-74. PubMed ID: 17141355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New York's generic drug substitution law.
    Kamen A
    N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574
    [No Abstract]   [Full Text] [Related]  

  • 7. Substitution--the New York State experience.
    DeNuzzo RV
    Med Mark Media; 1981 Jan; 16(1):25-9. PubMed ID: 10249801
    [No Abstract]   [Full Text] [Related]  

  • 8. Physicians' willingness and barriers to considering cost when prescribing.
    Tseng CW; Buenconsejo-Lum L; Manlucu L; Hixon A
    Hawaii Med J; 2006 Nov; 65(11):318, 320-1. PubMed ID: 17265992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes of pharmacists and physicians toward Florida's drug product selection law.
    Vuturo GJ; McCormick WC; Krischer JP
    Contemp Pharm Pract; 1980; 3(3):156-62. PubMed ID: 10247871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ohio Generic Product Selection Law: influence on pharmacy practice.
    Hunter RH
    Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269
    [No Abstract]   [Full Text] [Related]  

  • 11. Generic substitution laws--physicians' liability.
    Trout ME
    J Leg Med (N Y); 1977 Jul; 5(7):14-6. PubMed ID: 301915
    [No Abstract]   [Full Text] [Related]  

  • 12. Physicians' opinions and experiences of the Pharmaceutical Benefits Reform.
    Andersson K; Jörgensen T; Carlsten A
    Scand J Public Health; 2006; 34(6):654-9. PubMed ID: 17132599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic drug substitution law. Open letter from Attorney General Robert Abrams.
    Abrams R
    N Y State J Med; 1979 Jul; 79(8):1243. PubMed ID: 287925
    [No Abstract]   [Full Text] [Related]  

  • 14. Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?
    Granlund D
    Soc Sci Med; 2009 Dec; 69(11):1643-50. PubMed ID: 19815322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The real costs of generic substitution.
    Ballin JC
    N Y State J Med; 1988 Mar; 88(3):121-2. PubMed ID: 3357610
    [No Abstract]   [Full Text] [Related]  

  • 16. Two U.S. agencies offer generic drug law.
    Fisher MJ
    Natl Underwrit Life Health; 1979 Jan; 83(2):2, 7. PubMed ID: 10239881
    [No Abstract]   [Full Text] [Related]  

  • 17. Physician and pharmacist attitudes toward a generic incentive program.
    Colaizzi JL; Barone JA
    N J Med; 1986 Mar; 83(3):153-6. PubMed ID: 3458036
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescription versus cheapest drug substitution.
    Lepp BA; Defelice SL
    N Y State J Med; 1975 Jan; 75(1):133-5, 146. PubMed ID: 1053813
    [No Abstract]   [Full Text] [Related]  

  • 19. Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers.
    Bongiorno RA; Nutescu EA
    Semin Thromb Hemost; 2004 Dec; 30(6):619-26. PubMed ID: 15630667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic issues in the antisubstitution controversy.
    Sharpe TR
    Am J Pharm Sci Support Public Health; 1977; 149(2):53-9. PubMed ID: 910879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.